Exact Mass: 666.2417

Exact Mass Matches: 666.2417

Found 19 metabolites which its exact mass value is equals to given mass value 666.2417, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

taxuchin B

C33H43ClO12 (666.2443)

SCHEMBL16558847

C39H38O10 (666.2465)

PtdIns-(5)-P1 (1,2-dioctanoyl)

1-(1,2-dioctanoylphosphatidyl)inositol-5-phosphate, diammonium salt

C25H48O16P2 (666.2417)

Sildenafil citrate

C28H38N6O11S (666.2319)

D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt)

1-(1,2-dioctanoylphosphatidyl)inositol-3-phosphate, disodium salt

C25H48O16P2 (666.2417)

PtdIns-(4)-P1 (1,2-dioctanoyl)

1-(1,2-dioctanoylphosphatidyl)inositol-4-phosphate, diammonium salt

C25H48O16P2 (666.2417)

A 1-phosphatidyl-1D-myo-inositol 3-phosphate in which both phosphatidyl acyl groups are specified as octanoyl.

(2r)-3-{[(S)-Hydroxy{[(1r,2r,3r,4r,5s,6r)-2,3,5,6-Tetrahydroxy-4-(Phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-Diyl Dioctanoate

C25H48O16P2 (666.2417)

1,2-Dioctanoyl-sn-glycero-3-phospho-(1-myo-inositol-5-phosphate)

C25H48O16P2 (666.2417)

A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as octanoyl.

[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-[6-(2,4-dihydroxyphenyl)-2-[4-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-2,6-dihydroxyphenyl]-4-(hydroxymethyl)cyclohex-3-en-1-yl]methanone

C39H38O10 (666.2465)

1,2-dioctanoyl-sn-glycero-3-phospho-(1D-myo-inositol-4-phosphate)

C25H48O16P2 (666.2417)

A 1-phosphatidyl-1D-myo-inositol 4-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl.

4,6,8-tris(acetyloxy)-5-(chloromethyl)-2,5,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl benzoate

C33H43ClO12 (666.2443)

5-(5-{6-[2,4-dihydroxy-3-(3-hydroxy-3-methylbutyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl}-6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol

C39H38O10 (666.2465)

(2s,3as,4s,4ar,5r,6s,8s,8as,9r,10r)-4,6,8-tris(acetyloxy)-5-(chloromethyl)-2,5,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-9-yl benzoate

C33H43ClO12 (666.2443)

5-{5-[(1r,5s,6r)-6-[2,4-dihydroxy-3-(3-hydroxy-3-methylbutyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-6-hydroxy-1-benzofuran-2-yl}benzene-1,3-diol

C39H38O10 (666.2465)

[(1s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pent-4-en-1-yl]oxysulfonic acid

[(1s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pent-4-en-1-yl]oxysulfonic acid

C30H51BrO9S (666.2437)

(8s,9s,10s,11r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-8-[(2e)-3-phenylprop-2-enoyl]-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-11-yl benzoate

C39H38O10 (666.2465)